We hypothesized that downregulation of XPC could increase the expression of lung cancer stem cell biomarkers and the cancer cell stemness, thereby affecting the occurrence of lung cancer and prognosis of lung cancer patients. This evidence concerns the gene XPC and lung carcinoma.